This is a nice read - but note, n=1 (out of n=45). One thing I found interesting that the article didn't explain in detail, is the fact that the subject appeared to develop a severe allergic reaction to the booster. https://www.statnews.com/2020/05/26/moderna-vaccine-candidate-trial-participant-severe-reaction/ … 1/
-
-
I’m curious why you’re optimistic about sterilizing immunity (though i don’t love the term). I’ve been optimistic as well, but a lot of cold water thrown the last couple weeks and I’m struggling to articulate the optimism.
-
Let me clarify - I *chose* to be optimistic
. Many compare SARS-2 immunity to common cold bCoVs, but I don't think we can do that-very different infections. For SARS and MERS we don't understand immunity, but I haven't heard of a SARS reinfection and SARS-2, much more like that - Nog 4 antwoorden
Nieuw gesprek -
-
-
No evidence reaction was allergic. Immune-mediated vaccine reaction, the type one would expect.
-
Thanks Matthew for weighing in. His first reaction sounds like that, but the reaction to the booster seems like it could have been an allergic reaction to the first shot. I'm not sure this is necessarily what we would/should expect?
- Nog 2 antwoorden
Nieuw gesprek -
-
-
We should start building state-wide plans now on the distribution of vaccines when they do come about. Who will get them first? How will distribution work effectively so every corner of America can get what they need?
Bedankt, Twitter gebruikt dit om je tijdlijn te verbeteren. Ongedaan makenOngedaan maken
-
Het laden lijkt wat langer te duren.
Twitter is mogelijk overbelast of ondervindt een tijdelijke onderbreking. Probeer het opnieuw of bekijk de Twitter-status voor meer informatie.